Navigation Links
Jazz Pharmaceuticals, Inc. Announces LUVOX CR Launch Plans and Reports Development Pipeline Progress at Investor Day Presentation
Date:3/13/2008

hase III clinical trial of JZP-6, with clinical sites in the U.S., Canada, Europe and South America, is approximately 30 percent enrolled. With successful results from these trials, Jazz Pharmaceuticals expects to submit a New Drug Application (NDA) to the FDA by the end of 2009. Fibromyalgia syndrome affects 6 to 12 million patients in the U.S., many of whom are treated with a polypharmacy approach and continue to look for new treatment options.

"In 2007, we made extraordinary progress in our later-stage development programs, which we have carefully selected to address significant unmet neurological and psychiatric medical needs in fibromyalgia syndrome, restless legs syndrome, recurrent acute repetitive seizures, epilepsy and bipolar disorder," said Dr. Saks. "These clinical programs are on track with our portfolio-building objectives, and we continue to add early-stage projects to expand our pipeline."

Jazz Pharmaceuticals announced that JZP-7, a proprietary transdermal gel formulation of ropinirole, is designed to provide an effective, once-a-day treatment of moderate to severe restless legs syndrome. JZP-7 has been successfully evaluated in one pharmacokinetic (PK) study, and a second PK study is near completion. Available results from both studies demonstrate that the product is well tolerated. Jazz Pharmaceuticals is currently planning to initiate a Phase III clinical trial in the fourth quarter of 2008. Restless legs syndrome affects up to 10 percent of the U.S. population.

Jazz Pharmaceuticals' product candidate for the treatment of recurrent acute repetitive seizures in patients with epilepsy, JZP-8, is designed to be a fast-acting intranasal spray providing a socially-acceptable treatment option. As previously announced, Jazz Pharmaceuticals has received orphan drug designation from the FDA for JZP-8. This novel formulation incorporates clonazepam, a widely prescribed benzodiazepine indicated for the chronic treatment of epilepsy. In
'/>"/>

SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Affinium Pharmaceuticals, Ltd. Announces Initiation of a Phase I Clinical Trial for AFN-1252, its Novel Anti-staphylococcal Antibiotic
2. Acura Pharmaceuticals, Inc. Announces Andrew Reddick, President & CEO, To Take Medical Leave and Appointment of Richard Markham as Chairman of the Board
3. Renhuang Pharmaceuticals, Inc. Retains CCG Elite
4. Lotus Pharmaceuticals, Inc. Implements Environmentally-friendly Cost Saving Strategies
5. Jazz Pharmaceuticals, Inc. to Announce Fourth Quarter and Full Year 2007 Financial Results on February 13, 2008
6. NuView Radiopharmaceuticals, Inc. Secures Exclusive Rights From Thomas Jefferson University for a Tumor-Specific Imaging Agent for the Diagnosis of Breast and Prostate Cancers
7. Jazz Pharmaceuticals, Inc. Announces Submission of Complete Response to FDA Approvable Letter for LUVOX(R) CR
8. Acura Pharmaceuticals, Inc. Announces Approval to List Shares on NASDAQ and Effective Feb. 4, 2008 a New Trading Symbol: ACUR
9. Acura Pharmaceuticals, Inc. Announces Appointment of George K. Ross as Director
10. Access Licenses MuGard(TM) to RHEI Pharmaceuticals, a Leading Specialty Pharmaceutical Company for Distribution in China and Certain Other Southeast Asian Countries
11. American Stock Exchange LLC to Delist Securities of Samaritan Pharmaceuticals, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... (PRWEB) October 01, 2014 Marriagelifeinsurance.com ... find life insurance for retired couples. , Senior ... provide financial security for their loved ones. A joint ... both insured persons pass away. , Life insurance ... expense life insurance can even be purchased online, as ...
(Date:10/1/2014)... October 01, 2014 Bedros Keuilian is ... Boot Camp fitness boot camps, he’s also considered the ... , with sold out business summits, a line of ... consultant to a recent Spike TV reality show to ... now is the time for personal trainers and fitness ...
(Date:10/1/2014)... First Warning Systems, a pioneer in early cancer ... body, announced the company is changing its name to ... of upcoming product releases. The initial focus will be ... initial focus will be an ‘Internet of Everthing,’ wearable ... changes over time,” said Rob Royea, president and CEO ...
(Date:10/1/2014)... and ATLANTA (PRWEB) October 01, 2014 ... security executive networking and relationship-marketing firm, announced ... Information Security Executive® and Project of the ... top-ranking decision makers representing organizations in financial ... Projects include large-scale technology endeavors that address ...
(Date:10/1/2014)... Join the more than 80 golfers who already have ... charity golf tournament to benefit Project HEAL, a not-for-profit organization ... afford treatment. The tournament will be held Monday, Oct. 6, ... The day-long event starts with 10:30 a.m. check-in and shotgun ... begin at 5 p.m. and will include an auction featuring ...
Breaking Medicine News(10 mins):Health News:Elderly Life Insurance - Find Life Insurance for Retired Couples! 2Health News:Bedros Keuilian Shares Tips on Selling Personal Training for the Holidays 2Health News:Bedros Keuilian Shares Tips on Selling Personal Training for the Holidays 3Health News:First Warning Systems Changes Name to Cyrcadia Health to Better Reflect Core Competency and Goals of Company 2Health News:First Warning Systems Changes Name to Cyrcadia Health to Better Reflect Core Competency and Goals of Company 3Health News:First Warning Systems Changes Name to Cyrcadia Health to Better Reflect Core Competency and Goals of Company 4Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 2Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 3Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 4Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 5Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 6Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 7Health News:Project HEAL Benefit Golf Tournament Gaining Momentum 2Health News:Project HEAL Benefit Golf Tournament Gaining Momentum 3
... person,s gene profile seems to dictate reponse, study finds , , ... seems to influence how he or she reacts to certain ... genes with medications may help save a patient,s life, experts ... observation. It,s a large study with hard clinical endpoints," said ...
... to American Heart Month, which is just ahead in ... Control and Prevention (CDC) shows that, since 1999, coronary ... by 25.8 percent and 24.4 percent, respectively. This ... for reducing deaths from coronary heart disease has been ...
... UCLA study shows that only about half of children ... cognitive defects commonly associated with the condition. ... where medication is rarely prescribed to treat ADHD, the ... to populations in which medication is widely used. ...
... Marcy Leger Joins Agency as Executive Vice President, Managing ... Life, a leading healthcare,communications network, announced that Marcy Leger ... of Euro RSCG Life LM&P New,York, as a result ... to David Paragamian, Partner, President of Euro RSCG Life ...
... 22 NASA will release a,report on an ... and,hold a media teleconference to discuss the report ... NASA requested an independent external committee,conduct a comprehensive ... same time, NASA,s Johnson Space Center, Houston, began ...
... Children of Alcoholics Offer ... on January 30, 2008, CLEVELAND, Jan. 22 ... the National Association of Children,of Alcoholics (NACOA) have partnered ... a free one-day training program. The seminar will,help participants ...
Cached Medicine News:Health News:Genetics Influence Blood Pressure Medications 2Health News:Genetics Influence Blood Pressure Medications 3Health News:Heart and stroke death rates steadily decline; risks still too high 2Health News:Heart and stroke death rates steadily decline; risks still too high 3Health News:Heart and stroke death rates steadily decline; risks still too high 4Health News:Study raises questions about diagnosis, medical treatment of ADHD 2Health News:Study raises questions about diagnosis, medical treatment of ADHD 3Health News:Euro RSCG Life LM&P Announces Growth of Leadership Team 2
(Date:10/1/2014)... Calif. , Oct. 1, 2014  SI-BONE, Inc., a ... Implant System, ® a minimally invasive surgical (MIS) device ... joint, today announced the expansion of its European operations with ... Eric Schaber as General Manager, Germany.  Mr. Schaber ... vice president of Europe , ...
(Date:10/1/2014)... , Switzerland , October 1, 2014 ... in Clinical Genomics and Next Generation Sequencing (NGS) data ... clinicians to run full cystic fibrosis analysis in a ... identification and characterisation of all types of variants in ... Until now, it has not been possible ...
(Date:9/30/2014)... Sept. 30, 2014  Hologic, Inc. (NASDAQ: ... Hologic,s President and Chief Executive Officer, will preside over ... 1, the first day of Breast Cancer Awareness Month. ... campaign focused on the important benefits of Hologic,s 3D ... FDA as clinically superior to traditional mammography. ...
Breaking Medicine Technology:SI-BONE, Inc. Announces European Expansion with Appointment of Eric Schaber as General Manager, Germany and Formation of GmbH 2SI-BONE, Inc. Announces European Expansion with Appointment of Eric Schaber as General Manager, Germany and Formation of GmbH 3SI-BONE, Inc. Announces European Expansion with Appointment of Eric Schaber as General Manager, Germany and Formation of GmbH 4Sophia Genetics Launches Full CFTR Analysis in Single Clinical Grade NGS Experiment 2Hologic to Kick Off National Breast Cancer Awareness Month at the October 1 NASDAQ Stock Market Opening Bell Ceremony 2Hologic to Kick Off National Breast Cancer Awareness Month at the October 1 NASDAQ Stock Market Opening Bell Ceremony 3
... Nov. 2, 2010 CareFusion Corp. (NYSE: CFN ... for the three months ended Sept. 30, 2010. ... line with our expectations, and highlighted a strong quarter for ... David Schlotterbeck, chairman and CEO of CareFusion. "In the first ...
... 2010 Fiscal first quarter revenue from continuing ... million Fiscal first quarter adjusted income from continuing ... per share Fiscal first quarter GAAP income from ... share Rx segment revenue grew 47 percent with ...
Cached Medicine Technology:CareFusion Reports First Quarter Fiscal 2011 Results; Reaffirms Fiscal 2011 Financial Guidance 2CareFusion Reports First Quarter Fiscal 2011 Results; Reaffirms Fiscal 2011 Financial Guidance 3CareFusion Reports First Quarter Fiscal 2011 Results; Reaffirms Fiscal 2011 Financial Guidance 4CareFusion Reports First Quarter Fiscal 2011 Results; Reaffirms Fiscal 2011 Financial Guidance 5CareFusion Reports First Quarter Fiscal 2011 Results; Reaffirms Fiscal 2011 Financial Guidance 6CareFusion Reports First Quarter Fiscal 2011 Results; Reaffirms Fiscal 2011 Financial Guidance 7CareFusion Reports First Quarter Fiscal 2011 Results; Reaffirms Fiscal 2011 Financial Guidance 8CareFusion Reports First Quarter Fiscal 2011 Results; Reaffirms Fiscal 2011 Financial Guidance 9CareFusion Reports First Quarter Fiscal 2011 Results; Reaffirms Fiscal 2011 Financial Guidance 10Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 2Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 3Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 4Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 5Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 6Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 7Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 8Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 9Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 10Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 11Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 12Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 13Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 14Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 15Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 16Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 17Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 18Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 19
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: